EDAP TMS SA : EDAP to Present a Corporate Update at the 30th Annual Piper Jaffray Conference

November 20, 2018

LYON, France, November 20, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will provide a corporate overview at the Piper Jaffray Conference, taking place November 27-29, 2018 in New York City.

EDAP TMS SA -- 30th Annual Piper Jaffray Conference Presentation DetailsDate: Thursday, November 29Time: 11:50am Eastern TimeWebcast: https://event.webcasts.com/starthere.jsp?ei=1222377&tp_key=c74f9bbbf5

About EDAP TMS SAA recognized leader in the global therapeutic ultrasound market for almost 40 years, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for urology using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in 2013 as the answer to all requirements for ideal prostate tissue ablation as a complement to the existing FDA cleared Ablatherm® Robotic HIFU and Ablatherm® Fusion. As a pioneer and key player in the field of extracorporeal shock wave lithotripsy (ESWL), EDAP TMS exclusively utilizes the latest generation of shock wave source in its Sonolith® range of ESWL systems. For more information on the Company, please visit http://www.edap-tms.com, and us.hifu-prostate.com.

CONTACTS: Blandine Confort Investor Relations / Legal Affairs EDAP TMS SA +33 4 72 15 31 50 bconfort@edap-tms.com

Investor Contact Jeremy Feffer LifeSci Advisors, LLC 212-915-2568 jeremy@lifesciadvisors.com

Update hourly